Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association–European Dialysis and Transplant Association Registry
Zdenka Hrušková(Charles University), Kitty J. Jager(Amsterdam University Medical Centers), Christoph Wanner(Universitätsklinikum Würzburg), Vianda S Stel(Amsterdam UMC Location University of Amsterdam), Carmen Martos(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), David Jayne(University of Cambridge), Vladimı́r Tesař(Charles University), Knut Aasarød(St Olav's University Hospital), Kathrin Eller(Medical University of Graz), Pietro Ravani(University of Calgary), Andries J. Hoitsma(Radboud University Nijmegen), Agneta Ekstrand(Helsinki University Hospital), Johan De Meester(AZ Sint-Lucas), James Heaf(Zealand University Hospital)
Cited by 62
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990